Financhill
Back

Allstate Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
57

ALL
Allstate

Last Price:
188.23
Seasonality Move:
4.24%
Sell
36

SRPT
Sarepta Therapeutics

Last Price:
124.65
Seasonality Move:
-1.39%
Buy
57
Allstate (ALL) is a Buy

Is Allstate a Buy, Sell or Hold?

  • The current Allstate [ALL] share price is $188.36. The Score for ALL is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • ALL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $124.53. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ALL Stock Price Chart

What is Allstate's stock price today?

  • The Allstate share price today is $188.36
    The current trend is moderately bullish and ALL is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $124.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

ALL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.62 Buy
Relative Strength Index (14 RSI): 55.09 Buy
Chaikin Money Flow: -462923 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (185.05 - 190.91) Buy
Bollinger Bands (100): (162.05 - 183.17) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.18 Sell
Relative Strength Index (14 RSI): 35.54 Sell
Chaikin Money Flow: -49995 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.27 - 135.95) Sell
Bollinger Bands (100): (123.89 - 147.49) Sell

ALL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 190.56 Sell
20-day SMA: 188.76 Sell
50-day SMA: 181.03 Buy
200-day SMA: 165.61 Buy
8-day EMA: 189.7 Sell
20-day EMA: 188 Buy
50-day EMA: 182.01 Buy
200-day EMA: 164.59 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 125.45 Sell
20-day SMA: 127.75 Sell
50-day SMA: 135.2 Sell
200-day SMA: 127.53 Sell
8-day EMA: 125.39 Sell
20-day EMA: 128.04 Sell
50-day EMA: 132.59 Sell
200-day EMA: 128.64 Sell

Allstate Earnings Growth & ALL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.75 per share, an increase next quarter of $0.51 per share, an increase this year of $16.19 per share, and an increase next year of $2.92 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

Allstate Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):